Perinatal phthalates exposure decreases fine-motor functions in 11-year-old girls: Results from weighted Quantile sum

Sharon Daniel1, Arin A Balalian2, Robin M Whyatt3

  • 1Department of Public Health and Pediatrics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva POB 653, Israel; Soroka Medical Center and Clalit Health Services, Southern District, Israel.

Environment International
|December 28, 2019
PubMed

Insights

Prenatal exposure to phthalate mixtures is linked to reduced fine motor skills in 11-year-old girls. This study highlights sex-specific effects of these common plasticizers on child development.

Area of Science:

  • Environmental Health
  • Developmental Toxicology
  • Reproductive Health

Background:

  • Phthalates are widely used industrial chemicals that can cross the placental barrier.
  • Prenatal phthalate exposure is associated with adverse neurodevelopmental and behavioral outcomes in children.
  • Previous research indicated sex-specific associations between single phthalates and motor function.

Purpose of the Study:

  • To investigate the association between prenatal exposure to a mixture of seven phthalate metabolites and motor function at age 11 years.
  • To examine sex-specific effects of phthalate mixtures on gross and fine motor skills.
  • To identify specific phthalate metabolites contributing to observed motor function deficits.

Main Methods:

  • Prospective cohort study (Columbia Center for Children's Environmental Health birth cohort).
  • Maternal urine samples analyzed for seven phthalate metabolites during the third trimester.
  • Motor function assessed using the Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) at age 11.
  • Weighted Quartile Sum (WQS) regression and linear regression models used for analysis, adjusting for covariates.

Main Results:

  • A significant decrease in fine-motor function was observed in females exposed to higher levels of the phthalate mixture (B = -2.7, p = 0.01).
  • No significant association was found between the phthalate mixture and gross-motor function in females or any motor function in males.
  • Specific non-DEHP metabolites (MBP, MBZP, MIBP) were most strongly associated with fine-motor deficits in females.
  • Secondary analysis revealed decreased gross and fine motor functions in females exposed to a sum of non-DEHP phthalates.

Conclusions:

  • Prenatal exposure to phthalate mixtures is associated with impaired fine-motor function in 11-year-old girls.
  • The findings suggest sex-specific vulnerabilities to phthalate-induced neurodevelopmental effects.
  • These results underscore the importance of evaluating phthalate mixtures in environmental health research.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
152
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K